It is certainly a refreshing change of pace when the Nobel Assembly recognizes research based on proven facts and evidence, rather than hopeful subjectivity in contributing to the venture capital funding channels forwarding the incredulous “green movement” and a preponderance of junk science.
A pair of scientists were awarded the Nobel Prize in cancer immunotherapy for their bold and innovative approach to unleash the full immune power of precarious T-cells, in successfully battling certain types of cancers, a natural treatment plan that may pave the way in replacing traditional methods such as chemotherapy and radiation, reports Science News.
James P. Allison and Tasuku Honjo both garnered lifetime achievement awards along with the $1 million prize for research into the intricacies of natural occurring T-cells and micromanaging the aggressive immune defenders with proteins to mount an attack on mutations to cells and organs. The revolutionary medical process potentially carries a significant risk for specific patients, as unleashing of the body’s natural defense systems, could result in an attack on non-cancerous sites. However, the vast majority of the test cases have achieved successful results marked by improvement in the conditions of patients.
The scientific eloquent manipulation of the T-cells, actually prevents the aggressive weapon of the immune system from harmlessly bonding with cancerous cells and allows free reign in fighting the disease. The process of “break release” treatment methods, give patients with little or no hope a mathematical chance for recovery, which was previously under a fraction of a percent. Unfortunately, pancreatic cancers do not respond to the influx proliferating T-cells, but the doors have been opened in fighting an array of lethal conditions, a proven breakthrough that benefits humanity.
Read the Science News story here.
